APAP

Generic: ACETAMINOPHEN

Manufacturer: Advance Pharmaceutical Inc.

Nonsteroidal Anti-inflammatory Drug [EPC]Corticosteroid [EPC]Benzodiazepine [EPC]Proton Pump Inhibitor [EPC]Vitamin C [EPC]
241,537
Total Reports
147,729
Serious Reports
47,159
Death Reports
30
Reported Reactions
Death Report Ratio: High (19.52%)

Patient Demographics

Male
79,690
Female
131,966

Reported Adverse Reactions (30)

Side effects reported in FDA adverse event reports for APAP.

# Reaction Reports % of Total
1 OFF LABEL USE 21,736
6.0%
2 FATIGUE 20,053
5.5%
3 DRUG INEFFECTIVE 17,834
4.9%
4 PAIN 17,808
4.9%
5 NAUSEA 17,268
4.8%
6 HEADACHE 16,369
4.5%
7 TOXICITY TO VARIOUS AGENTS 14,721
4.1%
8 DYSPNOEA 14,253
3.9%
9 ARTHRALGIA 14,120
3.9%
10 PYREXIA 13,987
3.9%
11 VOMITING 13,740
3.8%
12 DIARRHOEA 13,146
3.6%
13 RASH 12,236
3.4%
14 INFUSION RELATED REACTION 10,783
3.0%
15 PNEUMONIA 10,767
3.0%
16 MALAISE 9,998
2.8%
17 CONDITION AGGRAVATED 9,517
2.6%
18 DIZZINESS 9,444
2.6%
19 ASTHENIA 9,418
2.6%
20 PRURITUS 9,344
2.6%
21 DEATH 9,029
2.5%
22 NASOPHARYNGITIS 8,962
2.5%
23 JOINT SWELLING 8,800
2.4%
24 RHEUMATOID ARTHRITIS 8,711
2.4%
25 WEIGHT INCREASED 8,462
2.3%
26 SINUSITIS 8,294
2.3%
27 FALL 8,257
2.3%
28 HYPERTENSION 8,228
2.3%
29 HYPERSENSITIVITY 8,070
2.2%
30 COMPLETED SUICIDE 8,007
2.2%

Important Disclaimer

FDA adverse event reports are submitted voluntarily and do not prove causation. A reported reaction does not mean the drug caused it. Drugs with more users naturally have more reports. Always consult your doctor or pharmacist before making medication decisions.